The Department of Urology at the University of Wisconsin is home to research programs investigating mechanisms of disease, translating discoveries in the laboratory to clinical trials, and making experimental treatments available to our patients with complex and challenging conditions. Research funding is derived primarily from the National Institutes of Health and exceeds $2 million annually.
Basic research within the department is augmented by a dense array of research collaborations with investigators from a wide range of scientific disciplines both inside the medical school and on main campus. The portfolio of clinical research involves wide-ranging collaborations with other clinical departments. Our efforts in outcomes research and research in medical education continue to expand as do our international outreach and research collaborations. Financial support for formal research training of medical students, predoctoral students, and postdoctoral fellows is drawn from an array of training grants in which Urology faculty participate.
|
E. Jason Abel, MD
Dr. Abel conducts clinical, translational, and basic research in urologic oncology. He currently is involved in several projects focusing on the development and metastasis of kidney cancer. |
|
Sara Best, MD
Dr. Best’s research interests lie in the study of kidney cancer and disease using optics, the development of new technology for minimally invasive surgery, and urinary stone disease. |
|
Reginald C Bruskewitz, MD
Dr. Bruskewitz is studying surgical and pharmacological therapies for benign prostatic hyperplasia, with funding from the National Insitutes of Health, major pharmaceutical companies, and various study groups. |
|
Wade A Bushman, MD PhD
Dr. Bushman’s research interests include clinical research in bladder and pelvic floor dysfunction and basic research in prostate development and prostate cancer. |
|
Tracy M Downs, MD
Dr. Downs has a joint appointment with the UW Carbone Cancer Center, and his clinical research emphasizes developing new therapies for genitourinary cancers. Research Focus |
|
Walter J Hopkins, PhD
Dr. Hopkins’ research interests focus on urinary infections and prevention of urinary tract infections. One particular area of interest is the potential benefits of cranberries. |
|
David F Jarrard, MD
Dr. Jarrard has a joint appointment with the University of Wisconsin Comprehensive Cancer Center, and his clinical research emphasizes developing new therapies for genitourinary cancers. He has an active basic science laboratory and is funded through the National Institutes of Health to examine genetic and epigenetic alterations in prostate cancer. |
|
Sarah E McAchran, MD
Dr. McAchran’s research interests in female urology include optimization of care pathways to improve surgical outcomes and clinical outcomes of female pelvic floor reconstruction. |
|
Patrick H McKenna, MD, FACS, FAAP
Dr. McKenna’s research interests include antenatal urologic problems, incontinence, recurrent urinary tract infections, vesicoureteral reflux, DSD (disorders of sex development), urologic reconstruction and bilateral Wilm’s tumor. |
|
Timothy D Moon, MBChB
Dr. Moon’s current research focuses on developing laparoscopic techniques for patient treatment such as laparoscopic cryotherapy for kidney cancer. He is also involved with clinical trials of treatments for Prostatic diseases. |
|
Stephen Y Nakada, MD, FACS
Dr. Nakada’s research focuses on pathophysiology of the ureter and all aspects of urinary stone disease. His research is currently supported by the American Urologic Association. |
|
David R Paolone, MD
Dr. Paolone’s research interests are in the areas of Benign Prostate Hyperplasia (BPH) and penile disorders. |
|
Kristina Penniston, PhD
Dr. Penniston’s research interests include clinical nutrition research in kidney stones and prostate cancer. Specifically, she is interested in the efficacy of nutrition therapy in the prevention, management, and treatment of disease and on indicators of quality of life. |
|
William Ricke, PhD
Dr. Ricke’s research interests include prostate cancer. |
|
Bruce L Slaughenhoupt, MD, FAAP
Dr. Slaughenhoupt has research interests in kidney stone development, treatment and prevention in the pediatric population. |
|
John D Wegenke, MD
Dr. Wegenke’s research includes clinical studies related to Benign Prostatic Hyperplasia (BPH), Urinary Tract Infections, Overactive Bladder, and Erectile Dysfunction. |
|
Daniel H Williams IV, MD
Dr. Williams’ research interests in male infertility include the preservation of fertility in men with cancer, the effects of advanced paternal age and the environment on male reproductive potential, and clinical outcomes of male reproductive tract reconstructions. |
